Patents Assigned to Research
  • Patent number: 10444643
    Abstract: Lithographic exposure tool and method for operating thereof that includes modification of the tool (assessed based on the measurements of geometrical distortions caused, in the tool, by the exposure process and used to train the exposure tool) to ensure that such geometrical distortions are reduced for any chosen exposure process. The method includes processing first data (representing distortions caused by initial exposure run(s)) to estimate second data representing distortions that would occur for another exposure run); and forming a modified exposure tool by changing at least one of a) a geometrical path is a path along which the workpiece stage is repositioned during the operation of the exposure tool; b) one or more of a presence, position, orientation, size and shape of an optical component of an optical projection sub-system of the optical system of the exposure tool; and c) a parameter of scanning synchronization of the exposure tool.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: October 15, 2019
    Assignee: Nikon Research Corporation of America
    Inventors: Travis Bow, Fardad Hashemi, Henry Kin Heng Pang
  • Patent number: 10448501
    Abstract: A circuit structure includes an annular conductor, a conductive via and at least one extension conductor. The annular conductor extends along a direction. The conductive via is disposed in the annular conductor and extending along the direction. The at least one extension conductor is electrically connected to at least one end of the annular conductor and extending toward the conductive via.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: October 15, 2019
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventor: Shih-Hsien Wu
  • Patent number: 10441950
    Abstract: A device and method are proved for transferring a target from a first location to a second location. The target is bound to solid phase substrate to form a target bound solid phase substrate. The device includes transfer surface for receiving the target bound solid phase substrate thereon for transfer. The transfer surface movable between a first position wherein the transfer surface is aligned with the first location and spaced therefrom by a distance and a second position wherein the transfer surface is aligned with the second location. An alignment structure aligns the transfer surface with respect to the second location, with the transfer surface in the second position. A force is movable between an attraction position wherein the target bound solid phase substrate are drawn toward the transfer surface and a discharge position wherein the target bound solid phase substrate are free of the force.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: October 15, 2019
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: David J. Beebe, Ben P. Casavant, David J. Guckenberger, Scott M. Berry
  • Patent number: 10441568
    Abstract: Cyclic nitroxide compounds including, but not limited to, compounds having the general formula I: wherein the dashed line and R1-R8 are as defined herein, are disclosed herein for use in treating diseases and disorders of the respiratory tract and/or respiratory tract remodeling.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: October 15, 2019
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Sara Goldstein, Amram Samuni, Neville Berkman
  • Patent number: 10447402
    Abstract: An optical transceiver includes an optical transmitter and an optical receiver. The optical transmitter includes a laser diode configured to convert a current signal into an optical signal; a main driver comprising first and second output terminals that have a differential structure, the main driver configured to drive the first and second output terminals in response to differential input signals and to provide the current signal to the laser diode through the first output terminal; and an impedance balancer configured to match impedances of the first and second output terminals by adjusting the impedance of the second output terminal according to signal states of the first and second output terminals.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: October 15, 2019
    Assignees: SK HYNIX INC., KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
    Inventors: Chul Woo Kim, Sang Geun Bae, Hyun Su Park, Choong Hwan Lee
  • Patent number: 10441611
    Abstract: An object of the present invention is to provide a method for producing a mesenchymal stromal cell composition, comprising conveniently and aseptically separating high-purity amnion-derived MSCs by performing enzyme treatment only once. According to the present invention, the following are provided: a method for producing a mesenchymal stromal cell composition, comprising: performing enzyme treatment of an amnion with collagenase and thermolysin and/or dispase; and filtering the enzyme-treated amnion through a mesh; a method for producing a cryopreserved mesenchymal stromal cell composition; and a therapeutic agent comprising as an active ingredient the mesenchymal stromal cell composition for a disease selected from graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, or radiation enteritis.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: October 15, 2019
    Assignees: NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE, HYOGO COLLEGE OF MEDICINE, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, KANEKA CORPORATION
    Inventors: Kenichi Yamahara, Akihiko Taguchi, Toshihiro Soma, Shunsuke Ohnishi, Akira Kobayashi
  • Patent number: 10440897
    Abstract: A grafting method includes: making a cut surface of a scion and a cut surface of a rootstock contact with each other, and disposing sheet-like thermoplastic resin films facing each other across a contact part; and covering a periphery of the contact part with the thermoplastic resin films by ultrasonically welding the thermoplastic resin films.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: October 15, 2019
    Assignee: NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
    Inventors: Natsuki Nakayama, Keita Yoshinaga, Loan Thi Thanh Nguyen
  • Patent number: 10447008
    Abstract: A laser driver device is provided, which includes a control circuit, a driver circuit and a feedback circuit. The control circuit receives setup data and convert the setup data into a setup signal. The driver circuit receives the setup signal and generates a drive current according to the setup signal to drive a laser light source. The feedback circuit receives the setup data and the feedback signal of the laser light source and compares the setup data with the feedback signal to generate an adjust signal. The driver circuit receives the adjust signal and adjusts the drive current according to the adjust signal.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: October 15, 2019
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Yu-Cheng Song, Chih-Chun Chen, Fu-Shun Ho, Chien-Hung Lu
  • Patent number: 10441689
    Abstract: A method for manufacturing a bioactive implant including the steps of (a) forming a mixture of an bioactive agent and a setting agent capable of transitioning from a flowable state to a rigid state; (b) converting the mixture into a flowable state; and (c) transitioning the mixture into a solid state in a shape of the implant.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: October 15, 2019
    Assignee: Louisiana Tech Research Corporation
    Inventors: Jeffery Adam Weisman, Connor Nicholson, David Mills
  • Patent number: 10441789
    Abstract: The present invention relates to an interface means, especially an interface means for a medical device, comprising at least one or more lines, whereby the lines are configured such that each line has at least one specific functionality and/or is able to connect a first connection means with a second connection means, and at least one grouping and/or redistributing means, wherein the at least one grouping and/or redistributing means is configured such that the lines can be grouped and/or redistributed onto one or more lines and/or the functionality of lines can be grouped and/or redistributed onto one or more lines, preferably onto at least one single line. Furthermore, the present invention relates to a method for communicating a plurality of signals, in particular power and/or data signals and/or control signals, over a plurality of lines.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: October 15, 2019
    Assignee: Medtronic Bakken Research Center, B.V.
    Inventor: Jeroen Jacob Arnold Tol
  • Patent number: 10441917
    Abstract: Provided is a method for separating, from a raw gas containing a specific gas, the specific gas using a gas separation membrane module. The gas separation membrane module includes a housing and a gas separation membrane element enclosed in the housing. The gas separation membrane element includes a gas separation membrane including a hydrophilic resin composition layer for selectively allowing for permeation of the specific gas. The method includes the steps of: increasing pressure in an interior of the gas separation membrane module; increasing a temperature in the interior of the gas separation membrane module; and feeding a raw gas to the interior of the gas separation membrane module in that order.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: October 15, 2019
    Assignees: SUMITOMO CHEMICAL COMPANY, LIMITED, RENAISSANCE ENERGY RESEARCH CORPORATION
    Inventors: Takenori Kitaura, Hisaaki Miyamoto, Yudai Ota, Takehiro Nakasuji, Osamu Okada, Masaaki Teramoto
  • Patent number: 10443079
    Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desatorase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: October 15, 2019
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Surinder Pal Singh, Stanley Suresh Robert, Peter David Nichols, Susan Irene Ellis Blackburn, Xue-Rong Zhong, James Robertson Petrie, Allan Graham Green
  • Patent number: 10444259
    Abstract: A method for automatically calibrating a feedback system, comprising: receiving one or more input parameters associated with a feedback system; applying the one or more input parameters to a model of the feedback system; deriving one or more feedback parameters for the feedback system from the model by: optimizing the model for the feedback parameters, and applying a noise characteristic of the feedback system to the model; and automatically tuning the feedback system using the one or more derived feedback parameters.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 15, 2019
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Uri Sivan, Kfir Kuchuk, Itai Schlesinger
  • Patent number: 10448432
    Abstract: Systems and methods which provide for detection of a signal using resource elements in the frequency domain where the signal for which detection is provided is multiplexed with other signals having subcarrier spacing that is different than the signal for which detection is provided are disclosed. Embodiments may provide for detection of a physical random access channel (PRACH) signal in a cellular radio communication system using resource elements in the frequency domain, wherein the PRACH signal is multiplexed with signals of other channels (e.g., data and/or control channel signals) of the cellular radio communication system. A frequency domain filter, such as implementing inverse discrete Fourier transform (IDFT) with down-sampling using indices for PRACH recovery, may be utilized to extract PRACH samples from frequency domain resource elements provided in a resource grid corresponding to a different subcarrier spacing than that of the PRACH.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: October 15, 2019
    Assignee: Hong Kong Applied Science and Technology Research Institute Co., Ltd.
    Inventors: Yijing Chu, Yuxian Zhang, Man Wai Kwan, Eric Kong Chau Tsang
  • Patent number: 10447010
    Abstract: Provided herein are a method and apparatus for controlling the wavelength of an external-cavity wavelength-tunable laser. The reflectivity or transmittance characteristics of a wavelength depend on the phase difference between light reflected by a wavelength-tunable filter and parasitic reflective light. Thus, when the temperature of a module and current applied to a phase control electrode and an external reflector are changed, the characteristics are changed in a periodic manner. The present disclosure relates to a wavelength control algorithm of determining combinations of these parameters to set conditions having optimum chirping characteristics at a desired wavelength.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: October 15, 2019
    Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventor: Byung-Seok Choi
  • Patent number: 10446861
    Abstract: A flowing electrolyte fuel cell system design (DHCFC-Flow) is provided. The use of a flowing oxygen-saturated electrolyte in a fuel cell offers a significant enhancement in the cell performance characteristics. The mass transfer and reaction kinetics of the superoxide/peroxide/oxide ion (mobile oxygen ion species) in the fuel cell are enhanced by recirculating an oxidizing gas-saturated electrolyte. Recirculating oxygen-saturated electrolyte through a liquid channel enhances the maximal current observed in a fuel cell. The use of a oxygen saturated electrolyte ensures that the reaction kinetics of the oxygen reduction reaction are fast and the use of convection ameliorates concentration gradients and the diffusion-limited maximum current density. The superoxide ion is generated in situ by the reduction of the oxygen dissolved in the gaseous electrolyte. Also, a dual porosity membrane allows the uniform flow of fuel (e.g., methane) on the fuel side, without allowing phase mixing.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: October 15, 2019
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Divyaraj Desai, Vedasri Vedharathinam, Martin Joseph Sheridan, Ashish V. Pattekar, Craig Eldershaw, Rajesh Kumar Padmarajan, Gabriel Iftime
  • Patent number: 10441144
    Abstract: A method and system are disclosed for opening a workspace inside a lumen of a living creature are disclosed. Anchors may be affixed to opposite ends of the workspace. An extender may be distance anchors apart while they are affixed to the walls of the workspace. Distancing the anchors may unfold and/or stretch the lumen in the region of the workspace.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 15, 2019
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Igor Igov
  • Patent number: 10441570
    Abstract: This invention provides novel indole, indazole, benzimidazole, benzotriazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (SARD) compounds, pharmaceutical compositions and uses thereof in treating hyperproliferations of the prostate including pre-malignancies and benign prostatic hyperplasia, prostate cancer, advanced prostate cancer, castration resistant prostate cancer, other AR-expressing cancers, androgenic alopecia or other hyper androgenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels (through degradation) and/or activity (through inhibition) of any androgen receptor including androgen receptor-full length (AR-FL) including pathogenic and/or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: October 15, 2019
    Assignees: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, GTX, INC.
    Inventors: Ramesh Narayanan, Duane D. Miller, Thamarai Ponnusamy, Dong-Jin Hwang, Yali He, Jayaprakash Pagadala, Charles B. Duke, Christopher C. Coss, James T. Dalton
  • Patent number: 10441791
    Abstract: This document provides methods and materials involved in detecting and delivering neurochemical signals, electrophysiological signals, ions, or combinations thereof within a mammal. For example, systems that can include one or more implantable devices containing probes configured to detect neurochemical signals (e.g., neurotransmitter concentrations), electrical signals, ions, or combinations thereof and one or more implantable devices containing electrodes and/or microfluidic delivery components configured to deliver neurochemical signals (e.g., neurotransmitters), electrical signals, ions, or combinations thereof to one or more locations within a mammal are provided.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: October 15, 2019
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Kevin E. Bennet, Kendall H. Lee
  • Patent number: 10441686
    Abstract: The present invention relates to a stent having a functional material coated on a cell space (safe coating space) thereof. The stent of the present invention, as a stent having a space for mounting and coating drugs and other materials for expanding the functions of the stent, is highly feasible as an actual product in consideration of the structure, transfer device, and manufacturing process of the stent as a whole, and secures a coating space (safe coating space) of a functional material in a cell of the stent through quantitative and qualitative modelling. Since an additional increase in volume does not occur even when the stent is press-mounted in a transfer device as a result of mounting a radio marker or a drug in the coating space, the stent of the present invention has excellent radio opacity without obstructing the loading and deployment of the stent, and may stably mount a great amount of a functional drug.
    Type: Grant
    Filed: March 9, 2016
    Date of Patent: October 15, 2019
    Assignees: UTAH-INHA DDS & ADVANCED THERAPEUTICS RESEARCH CENTER, NEXTBIOMEDICAL CO., LTD.
    Inventors: Don Haeng Lee, Jong Chae Park, Dong Gon Kim, Choong Ryeol Choi